- Home
- BSRR vs PROK Comparison
BSRR vs PROK Comparison
Compare BSRR & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BSRR | PROK |
|---|---|---|
| Founded | 1977 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 479.7M | 331.2M |
| IPO Year | 2001 | 2021 |
Fundamental Metrics
Financial Performance| Metric | BSRR | PROK |
|---|---|---|
| Price | $33.04 | $2.46 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $38.50 | $7.40 |
| AVG Volume (30 Days) | 54.5K | ★ 537.0K |
| Earning Date | 05-05-2026 | 01-01-0001 |
| Dividend Yield | ★ 3.08% | N/A |
| EPS Growth | ★ 10.28 | N/A |
| EPS | ★ 3.11 | N/A |
| Revenue | N/A | ★ $76,000.00 |
| Revenue This Year | $11.74 | $1,010.19 |
| Revenue Next Year | $3.63 | N/A |
| P/E Ratio | $10.88 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $22.42 | $0.46 |
| 52 Week High | $38.60 | $7.13 |
Technical Indicators
Market Signals| Indicator | BSRR | PROK |
|---|---|---|
| Relative Strength Index (RSI) | 33.70 | 62.25 |
| Support Level | $32.65 | $2.09 |
| Resistance Level | $34.71 | $2.58 |
| Average True Range (ATR) | 1.34 | 0.15 |
| MACD | -0.48 | 0.03 |
| Stochastic Oscillator | 16.27 | 79.61 |
Price Performance
Historical ComparisonAbout BSRR Sierra Bancorp
Sierra Bancorp is a California-based bank holding company, which offers a range of retail and commercial banking services. it offers a wide range of deposit products and services for individuals and businesses including checking accounts, savings accounts, money market demand accounts, time deposits, retirement accounts, and sweep accounts. The company's lending activities cover real estate, commercial (including small business), mortgage warehouse, agricultural and consumer loans, and also offers commercial construction loans and multifamily and agricultural credit facilities among other types of real estate loans.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.